| 摘要 |
A pharmaceutical composition comprising trans(3S,4R)-3,4-dihydro-2,2-diméthyle-4-(2-oxopipéridine-1-yl)-6-pent afluoroéthyle-2H-1-benzopyran-3-ol('Compound I'), or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, and a pharmaceutically acceptable carrier therefor, wherein the composition comprises 0.2 to 0.9 mg or 1.1 to 1.9 mg or 2.1 to 3.0 mg of Compound I; a method for preparing such a composition and the use of such a composition in medicine. |
